Can one person ever know all the answers? It is unlikely, and functionally diverse groups have been found to often beat groups of high-performing individuals. The insights and next-level ideas that come from engaging with a group of diverse experts can bring real value. Let Coreva Scientific lead your next advisory board, Delphi panel, interviews, or survey.

If you are looking for a structured and collaborative method to engage with KOLs then advisory boards can help you gain new insights and advice to solve business problems. If not run well, there is the risk that you only get back what you want to hear. Through focused moderation, Coreva Scientific will help you uncover the real value in KOL feedback. We also recommend talking to KOLs that don’t use or support your product, a so called Antiboard. In this way you can learn where market growth is possible and challenge their thinking.

Sometimes data are unavailable or collecting reliable data is not feasible. For example, how would you collect data on the most appropriate care pathway? You cannot run a trial comparing all possible pathways. What if you need to validate assumptions for a model or come to a conclusion on which patients benefit most from your product. These are situations where a Delphi panel is required. A structured, validated method for reaching expert consensus: a Delphi panel is accepted as evidence by HTA bodies and is suitable for publication in clinical journals.

Stakeholders can have varying opinions and perspectives. There are times when you want to bring them together and form consensus (Delphi panel) and there are times when you need to understand their individual points of view. Interviews of payers, providers, or patients can provide valuable insights into how approach the market. An interview can bring critical business data to the table.

How many providers believe in my product? How important are adverse events to payers? When you need to quantify something then surveys are a great option to consider. Online surveys can access payers, providers, and patients from all round the world and data can be collected quickly and efficiently. Coreva Scientific have validated partners in recruitment of respondents to ensure that all the surveys we undertake are compliant and publishable.

Results from individual studies are impacted by setting specific factors (confounders). Combining results from multiple studies together, the impact of these confounders can be reduced and a clearer picture of a product value appears. Meta-analysis is a statistical method to compare two products across multiple studies. Network meta-analysis allows for more than two products to be compared. Meta-analysis is one of the highest forms of evidence.

In many cases it is not feasible for every patient to use your product as costs or other resource availability may be limiting. So which patients benefit most from your product? To answer this question we need to analyze the patient’s baseline data alongside product and outcomes data. This allows for patient targeting and true evidence-based medicine.

The evidence for your product should be built on scientific rationale and not on randomness. Appropriate statistical testing of outcomes should be performed. Before this, we need to ensure that the analysis (or clinical trial) is powered to detect an effect. Are 200 patients enough? Did you account for dropout? Let Coreva Scientific guide your analysis plan to ensure actionable data and outcomes.

Healthcare should not be a race to the bottom on price! Value in healthcare is providing patients and providers with benefits at reasonable cost. How your product balances costs and effectiveness is important and something that all health technology assessment agencies want to know. Let Coreva Scientific design and build an analysis that is optimized for your product.

Not sure where to focus your sales team? Then a hospital prioritization tool should help. Using data on hospitals in your target area, the tool lets your sales team weight, sort, and rank hospital features to find their most appropriate target.

Purchase price is one thing, but how much will it actually cost a buyer to introduce your product? Is a reorganization of their workforce or additional training required? Will your product result in cost savings elsewhere? Coreva Scientific answers these questions as part of developing a budget-impact model.

See our work: Impact of product X on procedure Y: model example

Evidence-based sales are increasing. A sales dossier uses the GVD to craft a sales narrative based on data. This is a large part of the work that we do at Coreva Scientific. Let our expertise guide you into producing the perfect sales dossier.

Distilling the data down to the essential evidence-based marketing messages is key to creation of a functional claims matrix. With our understanding of data, global healthcare systems, and regulatory and legal requirements, you can trust Coreva Scientific to provide you with messages that you can use.

Provide a new way to access critical information. Physicians, payers, and patients want access to up-to-date information from real people. They want to ask questions and be convinced of the value you can provide. Webinars are a great way to provide for many of your stakeholders.

“If a picture is worth a thousand words, then a video is worth a million.” As a standalone or as part of e-learning or training, Coreva Scientific’s communications team can create the video that you need.

Are you ready to submit a health technology assessment and want an impartial review of some key evidence? Coreva Scientific can give your model a full review and QC. Are the assumptions fair? Were data extracted correctly? Are the equations right? Was the relative risk used appropriately?

Value is built on evidence, and evidence on data. Coreva Scientific can review the data you have, identify other available data, and help you understand how feasible the next steps of your plan are. It is important to get it right the first time!